<ѻý>Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too!ѻý> A daily roundup of news on COVID-19 and the rest of medicine Jul 30, 2021
<ѻý>Improved Survival in Metastatic Uterine Cancer With Hysterectomy Plus Chemoѻý> Data extend surgery's advantage from locally advanced to distant metastases Jul 29, 2021
<ѻý>Call in the T-Cell Cavalry to Fight COVID in the Immunocompromisedѻý> Preliminary research suggests immunotherapy could play role in protecting vaccine non-responders Jul 29, 2021
<ѻý>More Data Support Active Surveillance for Small Renal Massesѻý> Most patients avoided surgery with no metastasis, better focus on aggressive disease Jul 27, 2021
<ѻý>Shingrix OK'd for Immunocompromised Adultsѻý> CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
<ѻý>Drug Combo Promising in Rare Mesotheliomaѻý> Small study showed "robust and durable" responses, with "meaningful prolongation of survival" Jul 19, 2021
<ѻý>A Patient Care App Diagnosed Me With Cancerѻý> No one should receive a serious diagnosis this way -- not even a doctor like myself Jul 16, 2021
<ѻý>Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drugѻý> Advisory committee rejected oral anemia drug for dialysis and non-dialysis patient populations Jul 16, 2021
<ѻý>Keytruda Before, After Surgery Improves Outcome in TNBCѻý> Results from KEYNOTE-522 show "practice-changing" impact on EFS Jul 15, 2021
<ѻý>'Acceptable' Lead in Drinking Water May Still Be Harmful to Patients With CKDѻý> No safe amount of lead in water for those with kidney disease, researchers warn Jul 15, 2021
<ѻý>Raise a Glass? Study Tallies Cancer Cases From Boozeѻý> Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
<ѻý>Juul Bought Out Medical Journal for $51Kѻý> E-cig maker sponsored nearly a dozen studies, took over journal as it awaits FDA ruling Jul 13, 2021
<ѻý>Did Getting a Colonoscopy Lead to Cleaner Living?ѻý> Results varied by severity of screening findings, researchers found Jul 13, 2021
<ѻý>Support for MRI-Targeted Biopsy in Prostate Cancer Screeningѻý> Large Swedish study showed the approach cut overdiagnosis, unnecessary biopsies Jul 09, 2021
<ѻý>Empathy: The Most Critical Skill in Medicineѻý> Caring for a patient means putting yourself in their shoes Jul 09, 2021 podcast
<ѻý>Response Soars With Anti-PD-1 Drug for HER2-Positive Stomach Cancerѻý> Almost 50% relative increase in ORR with pembrolizumab plus trastuzumab and chemotherapy Jul 08, 2021
<ѻý>Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer?ѻý> Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
<ѻý>PD-1 Inhibitor Boosts Survival in Treated Esophageal Cancerѻý> Benefit with China-developed tislelizumab in all patients and EU-North American subgroup Jul 06, 2021
<ѻý>Infusion Centers or EDs for Sickle Cell Crises?ѻý> Adults with SCD treated in infusion centers had improved outcomes in three key measures Jul 06, 2021
<ѻý>COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxedѻý> A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
<ѻý>Woman Loses 6-Year Battle With Mouth Tumorѻý> Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions Jul 04, 2021
<ѻý>Are Antibiotics Linked to Early-Onset Colorectal Cancer?ѻý> With cases increasing globally, researchers look to these commonly used drugs Jul 03, 2021
<ѻý>IVF Babies at No Increased Risk of Childhood Cancersѻý> No associations seen with intracytoplasmic sperm injection or frozen embryo transfer, study found Jul 02, 2021
<ѻý>House Members Argue for Puerto Rico Coal Plant Shutdownѻý> Plant is releasing toxic coal ash, sickening the nearby community, lawmakers and witnesses say Jul 01, 2021
<ѻý>'Clinically Meaningful' Survival Gain in Neuroendocrine Tumorsѻý> Near 1-year improvement with radionuclide agent misses statistical significance Jul 01, 2021
<ѻý>Adjuvant Combo Boosts Survival in Resected Pancreatic Cancerѻý> Four-month gain in OS with the addition of nab-paclitaxel to gemcitabine Jun 30, 2021
<ѻý>LDCT Screening Linked to Lower Risk of Brain Mets in Lung Cancerѻý> This observed reduction in risk may be due to a less aggressive tumor biology, said study author Jun 28, 2021
<ѻý>Do 'Robots' Offer Any Clear Surgical Advantage?ѻý> Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology Jun 28, 2021 video
<ѻý>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCCѻý> "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
<ѻý>Ethics Consult: Help Family Have 'Savior Child' for Marrow Donation? MD/JD Weighs Inѻý> You voted, now see the results and an expert's discussion Jun 25, 2021
<ѻý>Hold Off on Approving Anal Cancer Drug, Advisors Tell FDAѻý> ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
<ѻý>No Survival Benefit With All-Oral Regimen for Relapsed/Refractory Myelomaѻý> Prolonging PFS a positive, as advances make OS improvement harder to achieve Jun 18, 2021
<ѻý>AI for Radiation Therapy Works, but Is it Fully Trusted?ѻý> Most machine learning-generated plans selected over human plans in head-to-head comparison Jun 16, 2021
<ѻý>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻý> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻý>What's Guiding Prostate Cancer Care for Gay Men?ѻý> Research specific to this group has only scratched the surface Jun 16, 2021
<ѻý>Fixed-Duration, All-Oral Regimen Slows CLL Progressionѻý> Near-80% reduction in PFS hazard with ibrutinib-venetoclax versus obinutuzumab-chlorambucil Jun 16, 2021
<ѻý>The FDA Is Failing the American Peopleѻý> The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
<ѻý>How CAR T-Cell Therapy Measures Up in Follicular Lymphomaѻý> Better response rates and survival with axicabtagene ciloleucel versus external control group Jun 15, 2021
<ѻý>Zanubrutinib Tops Ibrutinib in Relapsed or Refractory CLLѻý> Better overall response rate, less cardiotoxicity, with second-generation BTK inhibitor Jun 14, 2021
<ѻý>Tweaking Maintenance Options in Metastatic CRCѻý> Two studies move the needle, but no major breakthroughs Jun 11, 2021